+499.5%
MRNA vs CLX
-20.9%
+520.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CLX | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.3% | -0.9% | -1.5% |
| 7D | +5.5% | -9.2% | +14.7% | +11.2% |
| 30D | +158.7% | -11.0% | +169.8% | +180.3% |
| 3M | +182.1% | +5.0% | +177.1% | +198.1% |
| 6M | +151.8% | -18.8% | +170.6% | +181.4% |
| YTD | +393.6% | -4.4% | +398.0% | +409.7% |
| 1Y | +499.5% | -21.9% | +521.3% | +600.6% |
| All | +499.5% | -20.9% | +520.3% | +600.6% |
Cumulative growth
Daily Returns
Daily percentage return beside CLX.
Daily Out/Under-Performance
Portfolio return minus CLX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CLX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CLX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling